Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTPA | P49638 | 2/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.40 |
| ▸ | PSEN1 | P49768 | 7/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 7/20 | 0.36 |
| ▸ | ACHE | P22303 | 7/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14950742 | 0.92 | TTPA (0.55) | TTPAPTPN1GSTO1PSEN1ALOX5 | |
| SCHEMBL16247656 | 0.83 | PSEN1 (0.52) | TTPAPTPN1GSTO1PSEN1BCHE | |
| SCHEMBL18779754 | 0.82 | PTGS1 (0.57) | TTPAPTGS1PTGS2CYP1A2CYP3A4 | |
| SCHEMBL14950754 | 0.82 | PTGS1 (0.57) | TTPAPTGS1PTGS2CYP1A2CYP3A4 | |
| SCHEMBL16247635 | 0.82 | PTPN1 (0.48) | TTPAPTPN1GSTO1PSEN1ALOX5 | |
| SCHEMBL9312772 | 0.80 | TTPA (0.76) | TTPAPSEN1ALOX5PTGS1PTGS2 | |
| SCHEMBL14948992 | 0.80 | PSEN1 (0.56) | TTPAPTPN1GSTO1PSEN1ALOX5 | |
| SCHEMBL14948984 | 0.80 | PSEN1 (0.56) | TTPAPTPN1GSTO1PSEN1ALOX5 | |
| SCHEMBL14950824 | 0.79 | PSEN1 (0.53) | TTPAPTPN1GSTO1PSEN1ALOX5 | |
| SCHEMBL16247641 | 0.76 | PSEN1 (0.56) | TTPAPTPN1GSTO1PSEN1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013067881-A1 | WATER-SOLUBLE VITAMIN E DERIVATIVE-MODIFIED AMPHIPHILIC ANTICANCER MEDICAMENT COMPOUND AND PREPARATION, METHOD FOR PREPARING THE COMPOUND, AND APPLICATION THEREOF | 南京美西宁医药科技有限责任公司 (CN) | 2013-05-16 | — | — | WO | disclosed |